Clinical trial
GM-CSF Before Surgery in Treating Patients With Localized Prostate Cancer
NCT00305669 · University of California, San Francisco, Other · Completed
Key facts
| NCT number | NCT00305669 |
|---|---|
| Title | GM-CSF Before Surgery in Treating Patients With Localized Prostate Cancer |
| Official title | A Pilot Study of Two Dose Schedules of Granulocyte Macrophage Colony-Stimulating Factor (GM-CSF) as Neo-Adjuvant Therapy in Patients With Localized Prostate Cancer |
| Lead sponsor | University of California, San Francisco, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Biological, Other, Procedure |
| Interventions | sargramostim, immunohistochemistry staining method, immunological diagnostic method, laboratory biomarker analysis, conventional surgery, neoadjuvant therapy |
| Enrollment | 24 |
| Start date | Jul 1, 2006 |
| Primary completion | Jan 1, 2011 |
| Completion | Jun 1, 2014 |
| First posted | Mar 22, 2006 |
| Last update posted | Jun 25, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: